RECRUITING

CHAAMP (Charlotte African American MGUS Project) Internal Pilot Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to identify multiple myeloma in the precancerous MGUS stage in order to reduce the risk of delayed diagnosis of multiple myeloma, decrease morbidity related to multiple myeloma at progression, and improve long term outcomes.

Official Title

CHAAMP (Charlotte African American MGUS Project) Internal Pilot Study

Quick Facts

Study Start:2025-03-01
Study Completion:2035-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06644625

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:30 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Self-identify as Black and/or African American
  2. * Age 30 years or older at the time of consent
  3. * Capable and willing to provide informed consent. NOTE: HIPAA (Health Insurance Portability and Accountability Act) authorization for the release of personal health information may be included in the informed consent or obtained separately
  4. * Reside in Charlotte, NC, or the surrounding area, based on self-report
  1. * Self-reported history of MGUS, SMM, MM, AL amyloidosis, plasma cell leukemia, solitary plasmacytoma, Waldenstrom Macroglobulinemia, and POEMS.

Contacts and Locations

Study Contact

Margarita Dzhanumova
CONTACT
704-754-3768
margarita.dzhanumova@atriumhealth.org

Principal Investigator

Manisha Bhutani, MD
PRINCIPAL_INVESTIGATOR
Atrium Health Wake Forest Baptist Comprehensive Cancer Center

Study Locations (Sites)

Atrium Health Levine Cancer
Charlotte, North Carolina, 28204
United States

Collaborators and Investigators

Sponsor: Wake Forest University Health Sciences

  • Manisha Bhutani, MD, PRINCIPAL_INVESTIGATOR, Atrium Health Wake Forest Baptist Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-01
Study Completion Date2035-01

Study Record Updates

Study Start Date2025-03-01
Study Completion Date2035-01

Terms related to this study

Keywords Provided by Researchers

  • multiple myeloma
  • hematology
  • plasma cell disorders

Additional Relevant MeSH Terms

  • Multiple Myeloma
  • Multiple Myeloma Progression
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Smoldering Multiple Myeloma (SMM)
  • Plasma Cell Disorders